SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-039728
Filing Date
2021-03-22
Accepted
2021-03-22 16:30:33
Documents
2
Period of Report
2021-03-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2022926-15_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2022926-15_3seq1.xml 3 1634
2 EXHIBIT 24.1 tm2022926d15_ex24-1.htm EX-24.1 7490
  Complete submission text file 0001104659-21-039728.txt   10515
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Issuer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SPRINGWORKS THERAPEUTICS 100 WASHINGTON BLVD STAMFORD CT 05902
Business Address
Ashar Bhavesh (Reporting) CIK: 0001849740 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39044 | Film No.: 21761672